As a further validation step, putative GBM CTC clusters, as well as a biopsy from the primary GBM of patient 4 were stained with the GBM marker SOX2, revealing SOX2-positive cells in both specimens (Supplementary Fig. 4d, e). This evidence concerns the gene SOX2 and glioblastoma.